Please Wait...

Molecular Marker Lab

Specialized biomarker services backed by unrivalled scientific expertise, fully validated technology and the highest quality standard.

Molecular Marker Lab - Highly Specialized Biomarker Services for Clinical Trials

Bioclinica Lab is a highly specialized service provider of biochemical marker analysis to the pharmaceutical and biotech industries. Our extensive panel of validated biomarkers serve as surrogate endpoints in support of global, multi-site, clinical trials – from phase I to IV – across a wide range of therapeutic areas. With over 15 years of experience, over 400 clinical trials supported, and over 1 million samples analyzed, we are committed to providing quality services for your clinical study.

BIOMARKER MENU

View our complete list of validated Biomarker assays.
LEARN MORE

BIOMARKER ANALYSIS

Automated methods for Biomarker detection and analysis.
LEARN MORE

CLINICAL LAB SERVICES

In house scientific and technical expertise.
LEARN MORE

QUALITY ASSURANCE

Rigorous QA and CAP accreditation.
LEARN MORE

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Today at #SCDM2018 be sure to catch the Technology Ignite session @SCDM_DataDriven where @bioclinica's Clean Patien… https://t.co/HPs0hrLWwO
bioclinica (18 hours ago)
RT @eClinical_Jen: Data Management times are a’changing! AI, Machine Learning, Blockchain, IoT. Leadership Forum at @SCDM_DataDriven #scdm2…
bioclinica (18 hours ago)
RT @virtue_insight: #VIphv We are delighted to announce our new Gold Sponsor @bioclinica for our 16th Pharmacovigilance 2018 https://t.co/h…
bioclinica (6 days ago)
RT @bioclinica: Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas R embra…
bioclinica (6 days ago)
Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas… https://t.co/iW7Q9DfVgQ
bioclinica (2 weeks ago)
Background & key considerations to help #pharma prepare for new FDA blood pressure draft guidance issued in May. Ac… https://t.co/07dJeeD35E
bioclinica (3 weeks ago)

Latest Blogs:

Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations